Notice ID: 77dc7257813deb2cd705396682f69208Special Notice
A--Performance of Good Clinical Practices (GCP) Compliant Clinical Trials of a Freeze Dried Plasma (FDP) Product of Support Efforts to Obtain Food and Drug Administration (FDA) Licensure
Archived on June 13, 2015. Full description on SAM.gov.
Overview
- Posted
- June 13, 2014
- Notice type
- Special Notice
- NAICS
- 541711: Classification Not Available
Notice details
- PSC
- A: RESEARCH AND DEVELOPMENT
- Last updated
- Dec 4, 2025
Identifiers
- Solicitation number
- W81XWH14R0059
- Notice ID
- 77dc7257813deb2cd705396682f69208
Description
The US Army has a requirement to develop and license a FDP product in accordance with the Department of Defense (DoD) Acquisition System, FDA regulations and guidelines, and industry best practices. In direct support of the US Army product development effort, the Government is seeking to obtain clinical trial and regulatory support in the performance of GCP compliant clinical trials of a FDP product (Pre-clinical, Phase I, Phase II and Phase III). The acquisition strategy for the FDP program will utilize a combination of a Cooperative Research and Development Agreement (CRADA) for manufacturing (CRADA partner will fund the manufacturing development) and a contract (subject of this solicitation notice) for conduct of clinical trials and regulatory/technical support. The CRADA partner will supply all clinical trial material for conduct of the clinical trials. The U.S. Army Office of The Surgeon General (OTSG) will be the regulatory sponsor of record for the Investigational New Drug (IND) application, but ultimately the CRADA partner will submit and manage the Biologics License Application (BLA).
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Shannyn Scassero, 301-619-2640 US Army Medical Research Acquisition Activity
Documents
No documents available.
Lifecycle
Solicitation:
W81XWH14R0059- Special NoticeCurrentJun 13, 2014
A--Performance of Good Clinical Practices (GCP) Compliant Clinical Trials of a Freeze Dried Plasma (FDP) Product of Support Efforts to Obtain Food and Drug Administration (FDA) Licensure
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
W81XWH14R0059
Archive Date
Jun 13, 2015